Biomarkers of disease recurrence in stage I testicular germ cell tumours

Nature Reviews Urology, Published online: 26 August 2022; doi:10.1038/s41585-022-00624-yStage I testicular germ cell tumour is restricted to the testicle and can be mostly cured by orchiectomy; however, many patients experience tumour relapse. In this Review, the authors describe advantages and limitations of the currently available predictive biomarkers of relapse in germ cell tumours, and discuss the need to identify new biomarkers to avoid patient overtreatment.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Source Type: research